Topic: endocrine & metabolic diseases (en)
Title: Diabetes and New Insulins.
Author: Inzucchi, S.; Rolla, A.; Umpierrez, G., eds.
Source: Chevy Chase, MD: Hormone Foundation. 2007. 1 p.
Availability: Available from Hormone Foundation. 8401 Connecticut Avenue, Suite 900, Chevy Chase, MD 20815. Phone: 1-800-467-6663. Email: hormone@endo-society.org. Website: www.hormone.org. Price: Available free of charge on website.
Abstract: This brief fact sheet provides an overview of diabetes and new insulins. Insulin is a hormone that takes the glucose from the bloodstream and carries it inside the body’s cells, where it is used for energy. Diabetes occurs when the pancreas does not produce enough insulin or when the body becomes resistant to the effects of insulin. Written in nontechnical language, the fact sheet answers common questions about the three major types of diabetes, how diabetes is treated, the different types of insulin, and new insulin analogs, including glargine, detemir, lispro, aspart, glulisine, and inhaled insulin. Readers are referred to the Hormone Foundation (www.hormone.org or 1–800–HORMONE) for more information. The fact sheet is also available in Spanish. 1 figure.

Format: Factsheet
Language: English.
Major Keywords: Endocrine Diseases and Disorders. Diabetes Mellitus. Insulin. Drug Therapy. Drug Effects. Patient Care Management.
Minor Keywords: Patient Education. Blood Glucose. Type 1 Diabetes. Type 2 Diabetes. Gestational Diabetes. Glargine Insulin. Aspart Insulin. Lispro Insulin. Glulisine Insulin. Inhaled Insulin. Bolus Insulin. Basal Insulin.
Publication Number: ENDC10124.
Return to Search Results